1 / 1

Enrolled & Randomized (n=245 )

Did not meet eligibility criteria (n=57) Other reasons: (n=14) Time commitment (n=5) Unable to contact (n=3) Concern for risks (n=2) Declined (n=1) Accrual met/enrollment closed (n=2) Unknown (n=1). Assessed for Eligibility (n=316 ). Enrolled & Randomized (n=245 ). 3·75 µg No adj.

van
Download Presentation

Enrolled & Randomized (n=245 )

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Did not meet eligibility criteria (n=57) • Other reasons: (n=14) • Time commitment (n=5) • Unable to contact (n=3) • Concern for risks (n=2) • Declined (n=1) • Accrual met/enrollment closed (n=2) • Unknown (n=1) Assessed for Eligibility (n=316) Enrolled & Randomized (n=245) 3·75 µg No adj. (n=28) 7·5 µg No adj. (n=29) 15 µg No adj. (n=27) 15 µg + AS03 (n=54) 3·75 µg + AS03 (n=53) 7·5 µg + AS03 (n=54) Dose 1 • Day 2 phone (n=53) • Day 8 visit (n=53) • Day 2 phone (n=54) • Day 8 visit (n=54) • Day 2 phone (n=27) • Day 8 visit (n=27) • Day 2 phone (n=29) • Day 8 visit (n=29) • Day 2 phone (n=28) • Day 8 visit (n=28) • Day 2 phone (n=54) • Day 8 visit (n=54) Dose 2 ineligible (n=1), abnormal clinical lab Dose 2 out-of-window (n=1) • Dose 2 ineligible (n=2) • Abnormal clinical lab • Illness, dermatitis after dose 1 • Dose 2 out-of-window (n=1) Dose 2 ineligible (n=5), all for abnormal clinical labs Dose 2 out-of-window (n=4) • Dose 2 ineligible (n=2) • HCV infection • Abnormal clinical lab • Dose 2 out-of-window (n=1) • Dose 2 ineligible (n=6) • abnormal clinical labs (n=3) • Ineligible at enrollment (n=2) • new medication (n=1) • Dose 2 out-of-window (n=2) Dose 2 ineligible (n=2), both for abnormal clinical labs Dose 2 refused (n=2) Dose 2 out-of-window (n=1) Per Protocol 3·75 µg + AS03 (n=44) 3·75 µg No adj. (n=25) 15 µg + AS03 (n=46) 7·5 µg No adj. (n=27) 15 µg No adj. (n=24) Dose 2 (Day 21) 7·5 µg + AS03 (n=49) • Day 21 blood (n=27) • Day 23 phone (n=24) • Day 29 visit (n=27) • Day 42 visit (n=27) • Day 81 visit (n=27) • Day 141 phone (n=27) • Day 201 visit (n=27) • Day 386 visit (n=26) • Day 21 blood (n=27) • Day 23 phone (n=25) • Day 29 visit (n=28) • Day 42 visit (n=28) • Day 81 visit (n=28) • Day 141 phone (n=28) • Day 201 visit (n=28) • Day 386 visit (n=28) • Day 21 blood (n=29) • Day 23 phone (n=26) • Day 29 visit (n=28) • Day 42 visit (n=28) • Day 81 visit (n=28) • Day 141 phone (n=28) • Day 201 visit (n=28) • Day 386 visit (n=27) • Day 21 blood (n=54) • Day 23 phone (n=45) • Day 29 visit (n=53) • Day 42 visit (n=51) • Day 81 visit (n=51) • Day 141 phone (n=51) • Day 201 visit (n=51) • Day 386 visit (n=50) • Day 21 blood (n=53) • Day 23 phone (n=43) • Day 29 visit (n=51) • Day 42 visit (n=51) • Day 81 visit (n=52) • Day 141 phone (n=50) • Day 201 visit (n=48) • Day 386 visit (n=47) • Day 21 blood (n=53) • Day 23 phone (n=49) • Day 29 visit (n=52) • Day 42 visit (n=51) • Day 81 visit (n=51) • Day 141 phone (n=50) • Day 201 visit (n=48) • Day 386 visit (n=47)

More Related